BioTime (Israel) Profile

BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing products addressing degenerative diseases based on pluripotent stem cells and HyStem celldrug delivery platform technologies primarily in the United States and Israel. BioTime, Inc. was founded in 1990 and is based in Alameda, California. BioTime operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 92 people. more
Co-CEO, DirectorMichael WestView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business Address1010 Atlantic Avenue
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Phone510 521 3390
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterSeptember 30, 2018
Last Fiscal Year EndDecember 31, 2017

BioTime Directors

BioTime Corporate Directors

Michael Mulroy Director
David Schlachet Independent Director
Deborah Andrews Independent Director
Check also Trending Equities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..